Kim Witczak | International Drug Safety Advocate and Speaker

Kim Witczak | International Drug Safety Advocate and Speaker

• Kim is an International Drug Safety Advocate and Speaker.
• She was instrumental in helping to get the FDA black-box suicide warnings added to anti-depressants in 2004 and 2006.

Podcast: Play in new window | Download

Follow TBCY RSS

In the labyrinthine world of pharmaceuticals, ensuring the safety of drugs is a critical yet often overlooked aspect. Meet Kim Witczak, an international drug safety advocate and speaker hailing from Minneapolis, USA. Kim’s journey is marked by personal tragedy turned into a tireless crusade for accountability and transparency in the pharmaceutical industry. In this conversation, we delve into Kim’s insights, challenges, and victories in her quest for safer drugs and a more ethical pharmaceutical landscape.

[00:31] – About Kim Witczak

• Kim is an International Drug Safety Advocate and Speaker.
• She was instrumental in helping to get the FDA black-box suicide warnings added to anti-depressants in 2004 and 2006.
• Kim is currently a consumer representative on the FDA Psychopharmacologic Drug Advisory Committee.
• She has been recognised and felicitated several times.

[08:20] – What are some common misconceptions about drug safety that you have encountered?

• The assumption is that all FDA-approved drugs are inherently safe and effective.
• People often overlook the complexities of how drugs are approved and the potential risks involved.

[09:32] – What strategies do you believe are most effective in holding pharmaceutical companies accountable for drug safety?

• Litigation plays a crucial role in holding pharmaceutical companies accountable.
• It allows for thorough investigations and discovery processes. 
• Transparency, whistleblower protection, and consumer advocacy also contribute to increased accountability.

[22:03] – What advice would you give to individuals who have experienced adverse drug effects?

• Prioritise personal safety and report adverse effects to healthcare providers and regulatory agencies like the FDA. 
• Advocating for oneself, seeking support, and staying informed are crucial steps in navigating such experiences.

RESOURCES:

Learn more about Kim Witczak: LinkedIn

Enjoyed this podcast?

If you learned new insights about drug safety, subscribe and share them with friends!

Love to give us 5 stars? ⭐⭐⭐⭐⭐ If you do, we’d love a review from you. Help us reach more people to keep them in the know as we talk to leaders, high achievers, and thought leaders from diverse backgrounds and nationalities. Excellence can come from anywhere; stay in the know, and hear from emergent high achievers and gurus.

Stay updated with what’s shaping the world today through the latest The Brand Called You Podcast episode. Follow us on iTunes, Spotify, and Anchor.fm.  

You can find us at:

Website: www.tbcy.in 

Instagram: http://bit.ly/3HO7N06 

Facebook:http://bit.ly/3YzJOaD 

Twitter: http://bit.ly/3wMBOXK 

LinkedIn: https://www.linkedin.com/company/tbcy/ 

YouTube: http://bit.ly/3jmBqfq 

Chingari: https://chingari.io/tbcypodcast 

Moj:http://bit.ly/3wOrmPv 

Josh: http://bit.ly/3WWP0nB 

Thanks for listening! 

• Kim is an International Drug Safety Advocate and Speaker.
• She was instrumental in helping to get the FDA black-box suicide warnings added to anti-depressants in 2004 and 2006.
• Kim is currently a consumer representative on the FDA Psychopharmacologic Drug Advisory Committee.
• She has been recognised and felicitated several times.